Bone Marrow Transplantation - Table of Contents alert Volume ## Issue ##

Advertisement Wondering where to publish your next paper?   Frontiers is a community-oriented open-access publisher and research network. We are driving innovations around peer-review and a whole ecosystem of open science tools   Be a part of the future of research publication   TABLE OF CONTENTS Volume 48, Issue 7 (July 2013) In this issue Editorial Reviews Original Articles Letters to the Editor Advertisement SIOP 2013 - 45th Congress of the International Society of Paediatric Oncology 25th-28th September 2013 Hong Kong, China. The largest annual paediatric cancer meeting in the world on all cancer types affecting children, incl. leukemia and brain tumours. Register Now! * Discounts for SIOP members, Residents/Fellows, Nurses, Psychology & Psychosocial professionals, Parents/Survivors. www.kenes.com/siop   Editorial Top ‘A rose by any other name would smell as sweet’, or would it? R P Gale and H M Lazarus Bone Marrow Transplant 2013 48: 881-883; advance online publication, February 4, 2013; 10.1038/bmt.2012.275 Full Text Reviews Top Umbilical cord blood graft enhancement strategies: has the time come to move these into the clinic? M Norkin, H M Lazarus and J R Wingard Bone Marrow Transplant 2013 48: 884-889; advance online publication, September 3, 2012; 10.1038/bmt.2012.163 Abstract | Full Text Rescuing the neonatal brain from hypoxic injury with autologous cord blood Y Liao, M Cotten, S Tan, J Kurtzberg and M S Cairo Bone Marrow Transplant 2013 48: 890-900; advance online publication, September 10, 2012; 10.1038/bmt.2012.169 Abstract | Full Text Original Articles Top CONDITIONING REGIMENS Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML P Christopoulos, C Schmoor, M Waterhouse, R Marks, R Wäsch, H Bertz and J Finke Bone Marrow Transplant 2013 48: 901-907; advance online publication, February 4, 2013; 10.1038/bmt.2012.267 Abstract | Full Text In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study C Aristei, A Santucci, R Corvò, G Gardani, U Ricardi, G Scarzello, S M Magrini, V Donato, L Falcinelli, A Bacigalupo, F Locatelli, F Aversa, E Barbieri and Italian TBI working group:  Cynthia Aristei, Lorenzo Falcinelli, Gianni Gobbi, Carlo Raymondi, Franco Aversa, Antonella Santucci, Enza Barbieri, Andrea Ferri, Giuseppe Bandini, Andrea Pession, Stefano Maria Magrini, Filippo Bertoni, Marco Galelli, Sandro Tonoli, Michela Buglione di Monale e Bastia, Renzo Corvò, Franca Foppiano, Salvina Barra, Andrea Bacigalupo, Francesco Frassoni, Barbara Bruno, Giorgio Dini, Maura Faraci, Gianstefano Gardani, Cornelio Uderzo, Andrea Crespi, Giovanni Scarzello, Roberto Zandonà, Chiara Messina, Vittorio Donato, Lavinia Grapulin, Cinzia Di Felice, Elisabetta Di Castro, Anna Paola Iori, Walter Barbieri, William Arcese, Michele Troiano, Salvatore Parisi, Alberto Maiorana, Angelo Michele Carella, Umberto Ricardi, Giuseppe Rossi, Andrea Riccardo Filippi, Riccardo Ragona, Luigi Tomio, Rosa Bianca Guglielmi, Cristina Baiocchi, Paolo Scalchi, Roberto Raimondi, Cristiana Vidali S.C. and Natasha Maximova Bone Marrow Transplant 2013 48: 908-914; advance online publication, May 27, 2013; 10.1038/bmt.2013.66 Abstract | Full Text STEM CELL PROCUREMENT Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers S Giebel, T Kruzel, T Czerw, M Sadus-Wojciechowska, J Najda, E Chmielowska, S Grosicki, A Jurczyszyn, M Pasiarski, E Nowara, M Glowala-Kosinka, A Chwieduk, I Mitrus, A Smagur and J Holowiecki Bone Marrow Transplant 2013 48: 915-921; advance online publication, January 7, 2013; 10.1038/bmt.2012.269 Abstract | Full Text Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors Open M Schmitt, X Xu, I Hilgendorf, C Schneider, K Borchert, D Gläser, M Freund and A Schmitt Bone Marrow Transplant 2013 48: 922-925; advance online publication, January 14, 2013; 10.1038/bmt.2012.270 Abstract | Full Text CORD BLOOD STEM CELLS Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment J Kanda, L Kaynar, Y Kanda, V K Prasad, S H Parikh, L Lan, T Shen, D A Rizzieri, G D Long, K M Sullivan, C Gasparetto, J P Chute, A Morris, S Winkel, J McPherson, J Kurtzberg, N J Chao and M E Horwitz Bone Marrow Transplant 2013 48: 926-931; advance online publication, January 21, 2013; 10.1038/bmt.2012.279 Abstract | Full Text PEDIATRIC TRANSPLANTS Tandem high-dose chemotherapy and auto-SCT for malignant brain tumors in children under 3 years of age K W Sung, D H Lim, S H Lee, K H Yoo, H H Koo, J H Kim, Y-L Suh, Y S Joung and H J Shin Bone Marrow Transplant 2013 48: 932-938; advance online publication, January 14, 2013; 10.1038/bmt.2012.263 Abstract | Full Text Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients M Ansari, M A Rezgui, Y Théoret, C R S Uppugunduri, S Mezziani, M-F Vachon, C Desjean, J Rousseau, M Labuda, C Przybyla, M Duval, M Champagne, C Peters, H Bittencourt and M Krajinovic on behalf of the Pediatric Disease Working Parties of the European Blood and Marrow Transplant Group Bone Marrow Transplant 2013 48: 939-946; advance online publication, January 7, 2013; 10.1038/bmt.2012.265 Abstract | Full Text A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children’s Oncology Group study ANBL00P1 A E Seif, A Naranjo, D L Baker, N J Bunin, M Kletzel, C S Kretschmar, J M Maris, P W McGrady, D von Allmen, S L Cohn, W B London, J R Park, L R Diller and S A Grupp Bone Marrow Transplant 2013 48: 947-952; advance online publication, January 21, 2013; 10.1038/bmt.2012.276 Abstract | Full Text ALLOGRAFTING Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation D Sheppard, J Tay, A Bryant, S McDiarmid, L Huebsch, M Tokessy, L Hamelin, E Saidenberg and C Bredeson Bone Marrow Transplant 2013 48: 953-957; advance online publication, January 21, 2013; 10.1038/bmt.2012.264 Abstract | Full Text AUTOGRAFTING Clinical effect of individualized parenteral nutrition vs conventional method in patients undergoing autologous hematopoietic SCT M Tavakoli-Ardakani, B Neman, M Mehdizadeh, A Hajifathali, J Salamzadeh and M Tabarraee Bone Marrow Transplant 2013 48: 958-962; advance online publication, April 1, 2013; 10.1038/bmt.2012.280 Abstract | Full Text POST-TRANSPLANT EVENTS Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT) J A Steuter, M L H Villanueva, F R Loberiza, J O Armitage, R G Bociek, A K Ganti, S R Tarantolo, J M Vose, A Easley and P J Bierman Bone Marrow Transplant 2013 48: 963-965; advance online publication, December 10, 2012; 10.1038/bmt.2012.253 Abstract | Full Text In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden N Blijlevens, M de Château, G Krivan, W Rabitsch, A Szomor, R Pytlik, A Lissmats, H E Johnsen, T de Witte, H Einsele, T Ruutu and D Niederwieser on behalf of the CLWP of the EBMT Bone Marrow Transplant 2013 48: 966-971; advance online publication, December 17, 2012; 10.1038/bmt.2012.257 Abstract | Full Text New-onset microalbuminuria following allogeneic myeloablative SCT is a sign of near-term decrease in renal function T Morito, M Ando, T Kobayashi, K Kakihana, K Ohashi, H Akiyama, K Tsuchiya, K Nitta and H Sakamaki Bone Marrow Transplant 2013 48: 972-976; advance online publication, January 14, 2013; 10.1038/bmt.2012.271 Abstract | Full Text Citrulline and albumin as biomarkers for gastrointestinal mucositis in recipients of hematopoietic SCT W J F M van der Velden, A H E Herbers, R J M Brüggemann, T Feuth, J Peter Donnelly and N M A Blijlevens Bone Marrow Transplant 2013 48: 977-981; advance online publication, January 21, 2013; 10.1038/bmt.2012.278 Abstract | Full Text GRAFT-VERSUS-TUMOR EFFECTS Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study P G Medd, A J Peniket, T J Littlewood, R Pearce, J Perry, K E Kirkland, B E Shaw, M N Potter, C F Craddock, D W Milligan, A K Fielding, D I Marks and G Cook for the British Society of Blood and Marrow Transplantation (BSBMT) Bone Marrow Transplant 2013 48: 982-987; advance online publication, January 14, 2013; 10.1038/bmt.2012.261 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT T Daikeler, M Mauramo, A Rovó, M Stern, J Halter, A Buser, A Tyndall, P Häusermann, A Gratwohl, A Tichelli, M T Brennan and T Waltimo Bone Marrow Transplant 2013 48: 988-993; advance online publication, January 7, 2013; 10.1038/bmt.2012.260 Abstract | Full Text Letters to the Editor Top Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation A Antar, Z K Otrock, M Kharfan-Dabaja, Z Salem, S Aractingi, M Mohty and A Bazarbachi Bone Marrow Transplant 2013 48: 994-995; advance online publication, January 7, 2013; 10.1038/bmt.2012.256 Full Text Semi-ambulatory autologous peripheral blood SCT in 79 patients with multiple myeloma A C Gac, S Chantepie, E Marin, Q Cabrera, S Cheze, H Johnson, K Benabed, V Lefevre, A Batho, M Macro and O Reman Bone Marrow Transplant 2013 48: 996-997; advance online publication, January 28, 2013; 10.1038/bmt.2012.259 Full Text Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation Y Ito, T Miyamoto, Y Chong, T Aoki, K Kato, K Akashi and T Kamimura Bone Marrow Transplant 2013 48: 998-999; advance online publication, January 7, 2013; 10.1038/bmt.2012.268 Full Text KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation A Garfall, H T Kim, L Sun, V T Ho, P Armand, J Koreth, E P Alyea, R J Soiffer, J H Antin, J Ritz and C Cutler Bone Marrow Transplant 2013 48: 1000-1002; advance online publication, January 14, 2013; 10.1038/bmt.2012.272 Full Text Oncogenic driver supersedes BM preparation as the critical determinant of leukemic outcome: a one day protocol for BM harvest, infection and transplantation L J Beverly Bone Marrow Transplant 2013 48: 1003-1005; advance online publication, January 14, 2013; 10.1038/bmt.2012.273 Full Text Remission of Crohn’s disease after cord blood transplantation for leukocyte adhesion deficiency type 1 S Jain, P Gozdziak, A Morgan and R K Burt Bone Marrow Transplant 2013 48: 1006-1007; advance online publication, January 21, 2013; 10.1038/bmt.2012.274 Full Text Yellow fever vaccine viremia following ablative BM suppression in AML V I Avelino-Silva, F E Leal, E C Sabino, A S Nishiya, M da Silva Freire, F Blumm, V Rocha, C A Rodrigues, Y S Novis and E G Kallas Bone Marrow Transplant 2013 48: 1008-1009; advance online publication, January 21, 2013; 10.1038/bmt.2012.277 Full Text Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center C Solano, B Muñoz-Cobo, E Giménez, M J Remigia, P Amat, M A Clari, D Bravo, I Benet, J Montoro and D Navarro Bone Marrow Transplant 2013 48: 1010-1012; advance online publication, January 21, 2013; 10.1038/bmt.2012.286 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.